Related Experiment Video
Updated: Aug 9, 2025

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
Published on: October 12, 2013
Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner
Konrad Hoeft1, Gideon J L Schaefer1, Hyojin Kim2
1Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
Abstract:
Fibrosis represents the common end stage of chronic organ injury independent of the initial insult, destroying tissue architecture and driving organ failure. Here we discover a population of profibrotic macrophages marked by expression of Spp1, Fn1, and Arg1 (termed Spp1 macrophages), which expands after organ injury. Using an unbiased approach, we identify the chemokine (C-X-C motif) ligand 4 (CXCL4) to be among the top upregulated genes during profibrotic Spp1 macrophage differentiation. In vitro and in vivo studies show that loss of Cxcl4 abrogates profibrotic Spp1 macrophage differentiation and ameliorates fibrosis after both heart and kidney injury. Moreover, we find that platelets, the most abundant source of CXCL4 in vivo, drive profibrotic Spp1 macrophage differentiation. Single nuclear RNA sequencing with ligand-receptor interaction analysis reveals that macrophages orchestrate fibroblast activation via Spp1, Fn1, and Sema3 crosstalk. Finally, we confirm that Spp1 macrophages expand in both human chronic kidney disease and heart failure.
Insights
Researchers identified specific profibrotic macrophages (Spp1 macrophages) that drive organ fibrosis. Targeting chemokine ligand 4 (CXCL4) and these macrophages may offer new therapeutic strategies for fibrotic diseases.
Area of Science:
- Immunology
- Pathology
- Molecular Biology
Background:
- Fibrosis is a common endpoint of chronic organ damage, leading to tissue destruction and organ failure.
- Profibrotic macrophages play a critical role in the development and progression of fibrosis.
- Understanding the molecular mechanisms driving macrophage activation in fibrosis is crucial for developing targeted therapies.
Purpose of the Study:
- To identify and characterize novel cell populations involved in profibrotic processes.
- To elucidate the role of specific molecular mediators in macrophage-driven fibrosis.
- To explore potential therapeutic targets for mitigating organ fibrosis.
Main Methods:
- Unbiased gene expression profiling to identify markers of profibrotic macrophages.
- In vitro and in vivo models of heart and kidney injury.
- Genetic manipulation to assess the function of identified genes and cell populations.
- Single nuclear RNA sequencing and ligand-receptor interaction analysis.
Main Results:
- A distinct population of profibrotic macrophages, expressing Spp1, Fn1, and Arg1 (Spp1 macrophages), was identified and found to expand after organ injury.
- Chemokine (C-X-C motif) ligand 4 (CXCL4) was identified as a key upregulated gene during Spp1 macrophage differentiation.
- Loss of CXCL4 inhibited Spp1 macrophage differentiation and reduced fibrosis in cardiac and renal injury models.
- Platelets were identified as a major source of CXCL4, driving Spp1 macrophage differentiation.
- Macrophages orchestrate fibroblast activation through Spp1, Fn1, and Sema3 signaling pathways.
- Spp1 macrophages were found to be expanded in human chronic kidney disease and heart failure.
Conclusions:
- Spp1 macrophages represent a key cellular driver of organ fibrosis.
- CXCL4, primarily sourced from platelets, is essential for Spp1 macrophage differentiation and subsequent fibrosis.
- Targeting the CXCL4-Spp1 macrophage axis offers a promising therapeutic strategy for fibrotic diseases.
- Spp1 macrophages are relevant in human fibrotic conditions, including chronic kidney disease and heart failure.
More Related Videos
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Introduction to Fibroblasts
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Inflammation
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Differentiation of Common Myeloid Progenitor Cells

